PMID: 9422041Dec 1, 1995Paper

Medical ethics--when to stop treatment

Journal of Internal Medicine
J M Stanley

Abstract

Several misunderstandings regarding the question of when to stop treatment are examined by considering two frameworks for sorting out the different dimensions of the question. One framework addresses what is meant, and what is not meant, by 'stopping treatment'. The other plots various strategies of stopping treatment on a continuum of increasing degrees of invasiveness. While significant disagreements remain at important points, there is evidence of an emerging consensus in Western medicine: (1) that palliative care and counselling through the dying process should be increased whenever curative or life-sustaining treatment is curtailed; (ii) that any treatment that is not curative, but merely life-sustaining, should be stopped whenever a patient makes an authentic request to have it stopped; (iii) that genuinely futile treatment should not be offered even if requested; (iv) that much more thought and discussion is required to achieve a workable agreement about the definitions of 'futile' and 'inappropriate' treatment; and (v) that assistance in dying, although profoundly problematic, is no longer unthinkable.

References

Sep 1, 1992·Journal of Medical Ethics·C S Campbell
Aug 15, 1991·The New England Journal of Medicine·S H Miles
Mar 30, 1989·The New England Journal of Medicine·S H WanzerP Safar
Oct 3, 1987·Lancet·B Jennett
Oct 14, 1988·JAMA : the Journal of the American Medical Association·S J Youngner
Apr 12, 1984·The New England Journal of Medicine·S H WanzerJ van Eys
Aug 2, 1984·The New England Journal of Medicine
Apr 1, 1995·The Journal of Medicine and Philosophy·N S Jecker, L J Schneiderman
Apr 1, 1995·Journal of Medical Ethics·C Parkin
Apr 1, 1995·The Journal of Medicine and Philosophy·L M Kopelman
Apr 1, 1995·The Journal of Medicine and Philosophy·R Tong
Apr 1, 1995·The Journal of Medicine and Philosophy·G G Griener
Apr 1, 1995·Critical Care Medicine·C L SprungA Steinberg
Feb 1, 1995·Journal of Medical Ethics·D Seedhouse
Jun 24, 1995·BMJ : British Medical Journal·A Sommerville
Jun 1, 1993·Journal of Medical Ethics·K R MitchellT J Lovat
Feb 22, 1993·Archives of Internal Medicine·E H Loewy, R A Carlson
Sep 5, 1994·Health Policy·J Spiby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.